Patents Assigned to LifeCell Corporation
  • Publication number: 20240207488
    Abstract: The present disclosure provides a variety of methods and compositions e.g., solutions) useful for making, sterilizing, and preserving tissues (e.g., acellular tissue matrices). The disclosure also features the acellular tissue matrices made by the methods, which matrices can be used for a variety of applications such as, but not limited to, treating an injury to, or repairing, a large number of tissues and/or organs (e.g., fascia, bones, and/or cartilage) in a mammal (e.g., a human).
    Type: Application
    Filed: November 3, 2023
    Publication date: June 27, 2024
    Applicant: LifeCell Corporation
    Inventors: Wendell Sun, Jerome Connor, Qing-Qing Qiu, Rick T. Owens
  • Patent number: 11957814
    Abstract: The present disclosure provides tissue products produced from adipose tissues, as well as methods for producing such tissue products. The tissue products can include acellular extracellular matrices. In addition, the present disclosure provides systems and methods for using such products.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: April 16, 2024
    Assignee: LifeCell Corporation
    Inventor: Jerome Connor
  • Patent number: 11826488
    Abstract: Tissue product compositions and methods for treating a patient are provided. The tissue product composition may include a flowable carrier including a hyaluronic acid based material and acellular tissue matrix particles mixed within the carrier. Methods of producing the tissue product composition and an injection device filled with the tissue product composition are also provided.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: November 28, 2023
    Assignee: LifeCell Corporation
    Inventors: Hui Xu, Hui Li, Ming F. Pomerleau, Darin Messina
  • Patent number: 11724004
    Abstract: The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.
    Type: Grant
    Filed: October 6, 2020
    Date of Patent: August 15, 2023
    Assignee: LifeCell Corporation
    Inventors: Yi Chen, Sean Collins, Li Ting Huang, Eric Stec, Hui Xu
  • Patent number: 11717602
    Abstract: Systems, devices, and methods of the present disclosure assist with management of tubes and hoses during surgical procedures. The systems, devices, and methods provide for the proper opening and closing of tubes to facilitate performance of steps in a surgical procedure. Systems, devices, and methods of the present disclosure control fluid delivery to and from a medical device, including devices for tissue processing and cleaning.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: August 8, 2023
    Assignee: LifeCell Corporation
    Inventors: Evan J. Friedman, Israel James Jessop, Kai-Roy Wang, Aaron Barere, Brendan P. Collins, Derek Hugger, Christopher Labak, Scott Woodruff
  • Patent number: 11633521
    Abstract: The present disclosure provides tissue products produced from adipose tissues, as well as methods for producing such tissue products. The tissue products can include acellular tissue matrices for treatment of a breast.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: April 25, 2023
    Assignee: LifeCell Corporation
    Inventors: Hui Xu, Alexandra Pastino, Carrie Fang
  • Patent number: 11383007
    Abstract: The present disclosure relates to tissue matrix products. The products can includes tissue matrices that have holes or perforations located at certain positions to improve certain in vivo functions without substantial loss of strength or other important properties.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: July 12, 2022
    Assignee: LifeCell Corporation
    Inventor: Alexander Ringo
  • Patent number: 11298220
    Abstract: Techniques and devices for improved breast surgeries are provided. The devices can include tissue matrix and synthetic meshes for surrounding breast implants or tissue expanders to provide improved implant outcomes for pre-pectoral implantation or other implantation techniques.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: April 12, 2022
    Assignee: LifeCell Corporation
    Inventors: Kai-Roy Wang, Sangwook Park
  • Patent number: 11246994
    Abstract: Tissue product compositions and methods for treating a patient are provided. The tissue product composition may include a flowable carrier including a hyaluronic acid based material and acellular tissue matrix particles mixed within the carrier. Methods of producing the tissue product composition and an injection device filled with the tissue product composition are also provided. Methods of treating a hand of a patient are also provided.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: February 15, 2022
    Assignee: LifeCell Corporation
    Inventors: Hui Xu, Hui Li, Ming F. Pomerleau, Darin Messina
  • Publication number: 20220031911
    Abstract: The present disclosure provides devices and methods for treating a tissue site. The device and methods can be used to treat tissue that has been irradiated and can include a tissue matrix having the ability to support tissue regeneration and vascularization with cells from the tissue site.
    Type: Application
    Filed: December 3, 2019
    Publication date: February 3, 2022
    Applicant: LifeCell Corporation
    Inventors: Christopher A. Campbell, Patrick S. Cottler
  • Patent number: 11179505
    Abstract: Methods for producing crosslinked tissue matrices, crosslinked tissue matrices produced by such methods, as well as tissue products comprising such tissue matrices are disclosed. The methods comprise (1) dehydrating a collagen-containing tissue matrix to form a dehydrated collagen-containing tissue matrix; and (2) irradiating the dehydrated collagen-containing tissue matrix such that at least a portion of the dehydrated collagen-containing tissue matrix is crosslinked.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: November 23, 2021
    Assignee: LifeCell Corporation
    Inventors: Israel Jessop, Ming F. Pomerleau, Nathaniel Bachrach
  • Patent number: 11179235
    Abstract: Graft materials and devices for surgical breast procedures, as well as methods of making graft devices, are described.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: November 23, 2021
    Assignee: LifeCell Corporation
    Inventors: Melissa Richter Bowley, Aaron M. Barere, Evan J. Friedman, Nathaniel Bachrach
  • Patent number: 11123375
    Abstract: Compositions and methods for treating tissue are provided. The compositions may include tissue matrix derived from adipose tissue suitable for injection, small-volume implantation, or use as a soft-tissue regenerative material. Also provided are methods for producing such compositions.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: September 21, 2021
    Assignee: LifeCell Corporation
    Inventors: Hui Xu, Carrie Fang, Mrinal Shah, Israel James Jessop
  • Patent number: 11110201
    Abstract: Tissue compositions and methods of preparation thereof are provided. The tissue compositions can be used to treat or regenerate muscle tissue. The compositions can be configured to provide increased strength compared to other muscle matrices.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: September 7, 2021
    Assignee: LifeCell Corporation
    Inventors: Li Ting Huang, Eric Stec, Nathaniel Bachrach, Hui Xu
  • Patent number: 11090338
    Abstract: The present disclosure relates generally to methods of treatment of tissue prior to implantation. In one aspect, the methods of treatment include washing adipose tissue with detergents to improve the viability of adipose cells for implantation and/or to increase the amount of viable adipose cells per volume of tissue for implantation.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: August 17, 2021
    Assignee: LifeCell Corporation
    Inventors: Aaron Barere, Jerome Connor
  • Patent number: 11091733
    Abstract: Systems, devices, and methods of the present disclosure assist with management of tubes and hoses during surgical procedures. The systems, devices, and methods provide for the proper opening and closing of tubes to facilitate performance of steps in a surgical procedure. Systems, devices, and methods of the present disclosure control fluid delivery to and from a medical device, including devices for tissue processing and cleaning.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: August 17, 2021
    Assignee: LifeCell Corporation
    Inventors: Evan J. Friedman, Israel James Jessop, Kai-Roy Wang, Aaron Barere, Brendan P. Collins, Derek Hugger, Christopher Labak, Scott Woodruff
  • Patent number: 11045579
    Abstract: The present disclosure provides devices and methods for treating breasts. The devices can include an acellular tissue matrix having a predefined shape that allows for complete or enhanced coverage of an anterior portion of a breast implant or tissue expander or to support an implant and/or surrounding tissues.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: June 29, 2021
    Assignee: LifeCell Corporation
    Inventors: Aaron Barere, Sangwook Park, Kai-Roy Wang
  • Patent number: 11045583
    Abstract: The present application relates to a method and device for processing tissue. The method and device allow for machining of soft tissue samples to produce uniform shapes (e.g., uniform thicknesses) or reliably produce alterations such as openings or holes in soft tissue products. The method and device can alternatively or additionally be used to process tissue to produce particulates with desired properties.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: June 29, 2021
    Assignee: LifeCell Corporation
    Inventor: Israel James Jessop
  • Patent number: D983030
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: April 11, 2023
    Assignee: LifeCell Corporation
    Inventors: Barbara L. Merboth, Jennifer Hwang, Suranga Suraweera
  • Patent number: D1010122
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: January 2, 2024
    Assignee: LifeCell Corporation
    Inventor: John Wixted